Kappa CD28 T cell therapy / Baylor College of Medicine 
Welcome,         Profile    Billing    Logout  
 2 Diseases   1 Trial   1 Trial   5 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kappa CD28 T cell therapy / Baylor College of Medicine
CHARKALL, NCT00881920: Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma,

Recruiting
1
54
US
Kappa CD28 T cells
Baylor College of Medicine, The Methodist Hospital Research Institute, Center for Cell and Gene Therapy, Baylor College of Medicine
Lymphoma, Myeloma, Leukemia
01/25
07/35

Download Options